Dialysis of Drugs Guide

Downloads
Revenue

Description

The guidelines contained in this application are designed to provide extensive, easy-to-read information regarding the dialyzability of drugs. Numerous literature sources have been used in preparing the guidelines. For many drugs, including newly-approved medications, investigational agents and medications available in other countries, there have been no dialysis pharmacokinetic studies. In some cases, the available data may conflict. Conditions of dialysis used in published studies may not reflect current dialysis practice and technology. Variations in the duration of dialysis, blood and dialysate flow rates, dialysis membranes, and whether peritoneal dialysis is continuous or intermittent, will all affect drug removal. These guidelines distinguish between conventional hemodialysis and high permeability (high-flux) hemodialysis where such data are available. No information is provided on drug dialyzability with continuous renal replacement therapy (CRRT) or with plasmapheresis. For additional information on specific drugs, the reader should consult the primary literature.
Users of this application are referred to www.renalpharmacyconsultants.com for background and explanatory material to assist in the interpretation of the tabular data. The website provides specific information about factors that influence drug dialyzability and special considerations, such as CRRT, plasmapheresis and drugs of abuse. Users must be familiar with this information prior to using the content of this application. The website also includes a table presenting sieving coefficient data from in vitro and in vivo evaluations, which can be used to predict dosing requirements in CRRT, and a table regarding removal of drugs of abuse.
The app requires a one year auto-renewing subscription to access application data. It will auto-renew unless you cancel the subscription, which you can do at any time.
Terms of Service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Hide Show More...

In-Apps

One Year Subscription.
Rp 349ribu
One Year Account Subscription
Rp 349ribu

Screenshots

Dialysis of Drugs Guide FAQ

  • Is Dialysis of Drugs Guide free?

    Yes, Dialysis of Drugs Guide is free to download, however it contains in-app purchases or subscription offerings.

  • Is Dialysis of Drugs Guide legit?

    ⚠️ The Dialysis of Drugs Guide app has poor ratings and negative feedback. Users seem unsatisfied with its performance or features.

    Thanks for the vote

  • How much does Dialysis of Drugs Guide cost?

    Dialysis of Drugs Guide has several in-app purchases/subscriptions, the average in-app price is 349.00 Rp.

  • What is Dialysis of Drugs Guide revenue?

    To get estimated revenue of Dialysis of Drugs Guide app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Indonesia yet.
Ratings History

Dialysis of Drugs Guide Reviews

Great app

KLAURIE69 on

United States

I am a dialysis RN since 2016. They have developed this app over the years. Using this since 2016 and have not encountered a single issue with it. Very good source. Quick and ease access specially when I do beside dialysis and my primary RN wants to give meds during sessions. I got is first for a free trial and then bought a subscription. A Very small price for its usefulness.

Can’t Access

Thinking Me on

United States

I downloaded the app but was unable to purchase a subscription. I clicked the button for purchase, but the screen was blank, except for “Dialysis of Drugs”. So, I am unable to access the resource and don’t know how.

Will not open

DShermett on

United States

I purchased this, but it will not let me open it, telling me my password is wrong. I try to reset it, but it doesn’t send me the email to do so. Amendment: the company got back to me promptly after I contacted them and fixed my account. Still only three starts though since there is another app that gives me the same info for $.99 rather than 17.99/yr.

Reset password dies not Work!!!!

Nax-NJ on

United States

I want to reset my password but nothing was sent to my email to help me reset it. I already paid for the app. I want my money back .

Not worth $15.99

Llssh on

United States

I bought this app a few years ago. Now they want me to rebuy for a yearly fee. I think not. Treat your customers badly, you will lose them.

Great reference tool!

D&DsMum on

United States

I haven’t had any issues with this app.

RN

Acute nurse on

United States

I can't open the app, message says for me to repurchase a subscription, or use a coupon code or set up an account. I already purchased a subscription for $7.99. What gives?

How do I report this scam?!?!

S mumr on

United States

Asks for an annual subscription?? That's not an in-app purchase! That's scam

Cannot use at all!

WadeFL on

United States

App gives an Internet connection error every time it is opened, even when I am connected to the Internet and can access the Internet from other apps with absolutely no problems. Clicking 'Cancel' leads to a spinning "Loading" indicator that just spins and spins indefinitely. Completely unusable. I want my money back!

Not free! Don't bother!

Christina PK on

United States

The app says that it is free but requires you to buy a subscription before you can access anything. I guess I'll just stick to Google.

Store Rankings

Ranking History
Category Rankings
Chart
Category
Rank
Top Grossing
90
Top Free
364

Dialysis of Drugs Guide Competitors

Name
NKF KDOQI
Guidelines from the NKF
Dialysis Pro
Dialysis Management
KidneyDiet
Track Nutrients and Fluids
NephRef
Kidney Diet Friendly Recipes
Easy Meals for CKD Management
Arkana Labs Connect
ASN Kidney News
stdKtV Calculator
CRRT_Calc
A CRRT calculator.
kidney.wiki: learn kidneys
pediatric nephrology education

Dialysis of Drugs Guide Installs

Last 30 days

Dialysis of Drugs Guide Revenue

Last 30 days

Dialysis of Drugs Guide Revenue and Downloads

Gain valuable insights into Dialysis of Drugs Guide performance with our analytics.
Sign up now to access downloads, revenue, and more.